Financial Ratios Concord Biotech Limited

Revenues

Cost of Goods Sold, Total

Selling General & Admin Expenses, Total

Provision for Bad Debts

Depreciation & Amortization - (IS)

Other Operating Expenses

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Income (Loss) On Equity Invest.

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

Gain (Loss) On Sale Of Investments

Gain (Loss) On Sale Of Assets

Insurance Settlements

Income Tax Expense

Net Income to Company

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

Dividend Per Share

Payout Ratio

EBITDA

EBITA

EBIT

EBITDAR

Total Revenues (As Reported)

Effective Tax Rate - (Ratio)

Total Current Taxes

Total Deferred Taxes

Normalized Net Income

Interest on Long-Term Debt

Non-Cash Pension Expense

Marketing Expenses

Selling and Marketing Expenses

Research And Development Expense From Footnotes

Net Rental Expense, Total

Imputed Operating Lease Interest Expense

Imputed Operating Lease Depreciation

Maintenance & Repair Expenses, Total

Cash And Equivalents

Short Term Investments

Trading Asset Securities, Total

Accounts Receivable, Total

Other Receivables

Inventory

Prepaid Expenses

Other Current Assets, Total

Gross Property Plant And Equipment

Accumulated Depreciation

Long-term Investments

Other Intangibles, Total

Other Long-Term Assets, Total

Accounts Payable, Total

Accrued Expenses, Total

Short-term Borrowings

Current Portion of Long-Term Debt

Current Portion of Leases

Current Income Taxes Payable

Unearned Revenue Current, Total

Other Current Liabilities

Long-Term Debt

Long-Term Leases

Deferred Tax Liability Non Current

Other Non Current Liabilities

Common Stock, Total

Additional Paid In Capital

Retained Earnings

Total Common Equity

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent of Unfunded Proj. Benefit Obligation

Debt Equivalent Oper. Leases

Equity Method Investments, Total

Account Code - Inventory Valuation

Inventories - Raw Materials, Total

Inventories - Work In Process, Total

Inventories - Finished Goods, Total

Inventories - Others

Land - (BS)

Buildings, Total

Machinery, Total

Full Time Employees

Accumulated Allowance for Doubtful Accounts (Supple)

Net Income

Depreciation & Amortization - CF

Amortization of Goodwill and Intangible Assets - (CF)

Depreciation & Amortization, Total

Amortization of Deferred Charges, Total - (CF)

(Gain) Loss From Sale Of Asset

(Gain) Loss on Sale of Investments - (CF)

(Income) Loss On Equity Investments - (CF)

Provision and Write-off of Bad Debts

Other Operating Activities, Total

Change In Accounts Receivable

Change In Inventories

Change In Accounts Payable

Change in Other Net Operating Assets

Capital Expenditure

Sale of Property, Plant, and Equipment

Investment in Marketable and Equity Securities, Total

Other Investing Activities, Total

Short Term Debt Issued, Total

Long-Term Debt Issued, Total

Total Debt Issued

Short Term Debt Repaid, Total

Long-Term Debt Repaid, Total

Total Debt Repaid

Common Dividends Paid

Common & Preferred Stock Dividends Paid

Other Financing Activities, Total

Miscellaneous Cash Flow Adjustments

Cash Interest Paid

Cash Income Tax Paid (Refund)

Change In Net Working Capital

Net Debt Issued / Repaid